Navigation Links
Magnitude of overdiagnosis in cancer indicates need for strategies to address the problem
Date:4/22/2010

Many cancers detected by screening tests are not destined to cause symptoms or death and therefore represent a phenomenon known as overdiagnosis. And because overdiagnosis leads to unnecessary treatment and other harms, it is important to develop clinical and research strategies to quantify, recognize, and manage it, according to a review published online April 22 in the Journal of the National Cancer Institute.

H. Gilbert Welch, M.D. and William Black, M.D., of the Dept. of Veterans Affairs Medical Center, White River Junction, Vt. and the Dartmouth-Hitchcock Medical Center used data from large randomized screening trials to estimate the extent of overdiagnosis. They found that about 25% of breast cancers detected on mammograms and about 60% of prostate cancers detected with prostate-specific antigen (PSA) tests could represent overdiagnosis. In a lung cancer screening trial of chest x-rays and sputum tests, they estimate that 50% of the cancers detected represented overdiagnosis. They argue that this estimate will only increase with spiral CT scanning, which, in one observational study, found almost as many lung cancers in non-smokers as smokers.

The authors also point to cancer incidence and mortality statistics as evidence of overdiagnosis in some cancers. For five cancersthyroid, prostate, kidney and breast cancer, and melanomadata from the past 30 years show an increasing number of new cases but not an increase in deaths. In each of these cancers, an increase in screening or imaging tests has been associated with an increasing rate of new diagnoses.

In addition to screening, other procedures, such as diagnostic imaging, may contribute to overdiagnosis. CT colonography (virtual colonoscopy) for instance, often detects abnormalities outside the colon that can lead to more tests and possibly overdiagnosis.

The authors suggest several strategies to address the problem. One is to educate patients about the risks and benefits involved with early detection.

"Whereas early detection may well help some, it undoubtedly hurts others," they write. "Often the decision about whether or not to pursue early cancer detection involves a delicate balance between benefits and harmsdifferent individuals, even in the same situation, might reasonably make different choices."

Another strategy to reduce overdiagnosis is to raise the threshold at which a screening test result is labeled 'abnormal', or at which further steps are taken. For instance, investigators could test whether it was better to ignore small abnormalities detected on imaging tests, as is now the practice with lung nodules detected by CTscans.

"It is possible that new insights from genomics will ultimately allow us to more accurately predict tumor behavior at the individual level," the authors write. "However the field has not advanced to that point yet. We must explore other clinical strategies."

In an accompanying editorial, Laura Esserman, M.D., University of California, San Francisco and Ian Thompson, University of Texas Health Science Center at San Antonio, stress the critical importance of addressing the problem of overdiagnosis.

"What we need now in the field of cancer is the coming together of physicians and scientists of all disciplines to reduce the burden of cancer death AND cancer diagnosis," they write. "We must advocate for and demand innovation in diagnosis and management, fueled by science, harnessing modeling, molecular, and immunology tools to address this problem."


'/>"/>

Contact: Caroline McNeil
jncimedia@oxfordjournals.org
301-841-1286
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. International Medical Corps on the Ground in Chile, Following 8.8-Magnitude Earthquake
2. Remedy Needed for Overdiagnosis of Cancers
3. Targeted therapy prolongs life in patients with HER2-positive breast cancer
4. New Drugs, New Combinations Fight Breast Cancer
5. Study Finds Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
6. MDS Nordions TheraSphere(R) for Unresectable Liver Cancer (HCC) Now Covered by Two Large U.S. Insurers
7. National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short In Addressing Cancer Care Crisis
8. Panel calls for reducing colorectal cancer deaths by striking down barriers to screening
9. Lung Cancer: Large Impact, Little Funding
10. Inflammation marker related to obesity is elevated in patients with pancreatic cancer
11. Prolactin blocks oncogene associated with poor prognosis in breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... May 31, 2016 , ... Spartan Bioscience ... enables unprecedented portability and convenience. , The Cube is exceptionally small—it takes up ... the Cube fits easily into any space, whether in a hospital, doctor’s office, ...
(Date:5/31/2016)... CA (PRWEB) , ... May 31, 2016 , ... WaterField ... for digital-minded professionals, announces the waxed-canvas and leather Duo Dopp Kit , the ... waxed canvas or ballistic nylon, the Duo is smartly designed for Dad’s ...
(Date:5/31/2016)... ... May 31, 2016 , ... Phynd Technologies, Inc. announced recently the signing of ... TX and Shore Medical Center – Somers Point, NJ. The new clients range in ... demonstrating the breadth of Phynd’s solution and its interoperability. , Houston Methodist is a ...
(Date:5/31/2016)... ... May 31, 2016 , ... Advertising Age ... and statement solutions provider, for the tenth consecutive year as a Top 20 ... Advertising Age, and SourceLink ranked eighteenth in the “U.S. CRM/Direct Marketing Agency” category. ...
(Date:5/30/2016)... California (PRWEB) , ... May 30, 2016 , ... ... easy to use inside of FCPX," said Christina Austin - CEO of Pixel ... exclusively for use within Final Cut Pro X. Choose from abstract transitions to ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... New York , May 30, 2016 ... market report titled, "Advanced (3D/4D) Visualization Systems Market - ... 2016 - 2024." According to the report, the global ... 1.8 Bn in 2015 and is anticipated to expand ... to reach US$ 3.2 Bn in 2024. ...
(Date:5/30/2016)... May 30, 2016 On 28 May, ... hepatitis by 2030. At the 69 th World Health ... Viral Hepatitis Strategy, signalling the greatest global commitment in viral ... of eliminating hepatitis B and C by 2030 and includes ... will reduce annual deaths by 65% and increase treatment to ...
(Date:5/27/2016)... , May 27, 2016  A new study highlights the necessity of health literacy ... Journal of the American College of Radiology , a majority of oncology patients undergo ... Photo - http://photos.prnewswire.com/prnh/20160527/373022 ... ... Medical Diagnostic Imaging Ampronix ...
Breaking Medicine Technology: